Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016

Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016

In September 2015, 4CMenB meningococcal vaccine was introduced into the United Kingdom infant immunization program without phase 3 trial information. Understanding the effect of this program requires enhanced surveillance of invasive meningococcal disease (IMD) Neisseria meningitidis isolates and co...

Full description

Bibliographic Details
Main Authors: Charlene M.C. Rodrigues, Jay Lucidarme, Ray Borrow, Andrew Smith, J. Claire Cameron, E. Richard Moxon, Martin C.J. Maiden
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2018-04-01
Series:Emerging Infectious Diseases
Subjects:
Neisseria meningitidis
bacteria
genomic surveillance
molecular epidemiology
multilocus sequence typing
MLST
Online Access:https://wwwnc.cdc.gov/eid/article/24/4/17-1480_article

Internet

https://wwwnc.cdc.gov/eid/article/24/4/17-1480_article

Similar Items